• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

B8 Venture Partners

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Forest lands £27m Series B extension from VC investors to expand shared e-bike services across LondonForest lands £27m Series B extension from VC investors to expand shared e-bike services across London
    Forest
    28 Apr 2026

    Forest lands £27m Series B extension from VC investors to expand shared e-bike services across London

    Forest is a micromobility platform that provides shared e-bikes for urban transport in London. It enables users to access affordable cycling for short journeys, supporting sustainable travel across the city.

    Forest secures £13m in Series B funding to expand its operations and launch new e-bike modelsForest secures £13m in Series B funding to expand its operations and launch new e-bike models
    Forest
    22 Jan 2025

    Forest secures £13m in Series B funding to expand its operations and launch new e-bike models

    Forest operates a shared e-bike service focused on responsible urban mobility, combining free daily usage, fleet innovation and parking compliance to reduce car dependency in major cities.

B8 Venture Partners
    • Mobility
  • 1(12 months)
  • Update Information

More venture news

  • Yope raises a £9.2m Pre-Series A round led by Northzone to build private social platform for close friends
    Yope
    23 Jul 2026

    Yope raises a £9.2m Pre-Series A round led by Northzone to build private social platform for close friends

    ExtensionConsumer
  • Mach42 raises a £7m pre-Series A round led by IP Group to speed up analog circuit verification for semiconductor engineers
    Mach42
    21 Jul 2026

    Mach42 raises a £7m pre-Series A round led by IP Group to speed up analog circuit verification for semiconductor engineers

    ExtensionDeep Tech
  • Alchemab Therapeutics secures £25m Series A extension from British Business Bank to scale antibody drug discovery pipeline for hard-to-treat diseases
    Alchemab Therapeutics
    9 Jul 2026

    Alchemab Therapeutics secures £25m Series A extension from British Business Bank to scale antibody drug discovery pipeline for hard-to-treat diseases

    ExtensionLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn